Pharmaceuticals, Biotechnology and Life Sciences
Sanofi and GSK today announced teaming up to work on a vaccine for COVID-19, as Sanofi will contribute its S-protein COVID-19 antigen, and GSK contributing pandemic adjuvant technology.
BIOGGIO, Switzerland–(BUSINESS WIRE)–The KD Pharma Group (“KD Pharma”) and its partner, SLA Pharma (“SLA”), announced that its new drug candidate…
Tiziana Life Sciences said Thursday it has developed investigational new technology to treat COVID-19 infections.
Dynavax Technologies Corporation said Wednesday it is donating 10,000 doses of HEPLISAV-B adult vaccine to help protect healthcare professionals on the front lines of the COVID-19 response against hepatitis B.
GlaxoSmithKline and Vir Biotechnology have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19, in which GSK will make an equity investment in Vir of $250 million, to gain access to Vir’s technology.
Oxford Biomedica said Wednesday it has joined a Consortium lead by the Jenner Institute, Oxford University, to work on a potential vaccine candidate for COVID-19, called ChAdOx1 nCov-19.
ACG has introduced its first-ever AI-based blister inspection system that offers you a plethora of benefits. Surpassing the challenges of conventional inspection systems, this new system can take your production efficiency to the next level, bringing machine interaction closer to human interaction.
Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets.
Care Access Research on Friday said it was leading a validation trial with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.